All blog posts
Total 102 results for
Showing 36 out of 102 results
10 February 2025
Key Takeaways from the UPC Litigation Forum and Pharma & Biotech Patent Litigation Europe Summit 2025
30 January 2025
The UPC at 18 months
29 January 2025
Transparency at the UPC – accessing information, pleadings and evidence
09 January 2025
UPC's first anti-anti-suit injunction granted ex parte in SEPs dispute
27 November 2024
UPC busy with main action decisions and key appeals so far in November 2024
26 November 2024
First FRAND judgment of the UPC
13 November 2024
UPC Court of Appeal decides that national proceedings before the start of the UPC do not prevent withdrawal of opt-out
08 November 2024
UPC Milan Local Division gives its first main action decision
03 October 2024
FRAND in the UPC? – not quite yet
26 September 2024
Protecting SEPs in Europe: Insights into FRAND and UPC Developments
16 July 2024
UPC revokes Amgen's patent in the first case filed at the UPC
05 July 2024
Paris Local Division issues the second full UPC decision and applies the Brussels Regulation to maintain maximum jurisdiction
Showing 36 out of 102 results
View moreKey contacts
Rebekah Gay
Partner, Head of Intellectual Property, Sydney
Laura Orlando
Managing Partner, Milan Office, Milan
Sue Gilchrist
Consultant, Sydney
Peng Lei
Partner, Kewei, Mainland China and Shanghai
Alexandra Neri
Partner, Paris, Korea Group and Africa Group
Dr Ina vom Feld
Partner, Germany
Sebastian Moore
Partner, Head Intellectual Property, London and Milan
Rachel Montagnon
Knowledge Counsel, London